Boulle AM, Schomaker M, May MT, Hogg RS, Shepherd B, et al.
2014-09-09 • PLOS Medicine
2014-09-09 • PLOS Medicine
BACKGROUND High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Africa, compared to Europe and North America, is well documented. Longer-t...
Keiser O, Tweya H, Boulle AM, Braitstein P, Schechter M, et al.
2009-09-10 • AIDS
2009-09-10 • AIDS
BACKGROUND In high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring ...
Spaar A, Graber C, Dabis F, Coutsoudis A, Bachmann L, et al.
2010-06-01 • AIDS Care
2010-06-01 • AIDS Care
Expanded access to antiretroviral therapy (ART) offers opportunities to strengthen HIV prevention in resource-limited settings. We invited 27 ART programmes from urban settings in Africa...
Calmy A, Balestre E, Bonnet F, Boulle AM, Sprinz E, et al.
2012-12-01 • BMC Infectious Diseases
2012-12-01 • BMC Infectious Diseases
Changes in CD4 cell counts are poorly documented in individuals with low or moderate-level viremia while on antiretroviral treatment (ART) in resource-limited settings. We assessed the i...
Tassie JM, Malateste K, Pujades-Rodriguez M, Poulet E, Bennett DE, et al.
2010-11-10 • PLOS One
2010-11-10 • PLOS One
BACKGROUND: Retention of patients on antiretroviral therapy (ART) over time is a proxy for quality of care and an outcome indicator to monitor ART programs. Using existing databases (Ant...
